Research News and Research

RSS

Prolonged separation from mother increases risk of breast cancer in young mice

Young mice that experienced the psychosocial stress of prolonged separation from their mothers had a higher incidence and faster onset of breast tumors compared with young mice who did not experience this stressful life event. Specifically, neonatal mice separated from their mothers for a prolonged period of time developed mammary tumors twice as fast as mice that experienced short or no maternal separation.

8 Nov 2010

Health care industries have mixed reaction to health reform

The Wall Street Journal: While many Republican campaigns this season focused on repeal of the federal health care overhaul, "even with the House changing hands, health insurers, drug companies and hospitals said they were planning as if the law will stick." However, health-care companies "say that the election results offer new opportunities to influence the way the law is implemented.

8 Nov 2010

Clinical Data receives $500,000 grants under QTDP program

Clinical Data, Inc. today announced that the Company has received two grants totaling nearly $500,000 under the Qualifying Therapeutic Discovery Project.

8 Nov 2010

FDA approves Cymbalta for treatment of chronic musculoskeletal pain

The U.S. Food and Drug Administration today approved Cymbalta (duloxetine hydrochloride) to treat chronic musculoskeletal pain, including discomfort from osteoarthritis and chronic lower back pain. Cymbalta was first used to treat major depressive disorder in 2004.

8 Nov 2010

Alder to present data of ALD518 two clinical studies for rheumatoid arthritis at American College Meeting

Alder Biopharmaceuticals Inc. today announced that data from two clinical studies of its ALD518 investigational antibody therapeutic will be presented at the Annual Meeting of the American College of Rheumatology in Atlanta.

8 Nov 2010

Gout and hyperuricemia continue to rise in the U.S.

Gout rates and related cases of hyperuricema have increased over the past two decades, according to research presented at the Nov 2010, American College of Rheumatology Annual Scientific Meeting in Atlanta.

8 Nov 2010

'New framework' needed to reduce slum expansion, new UN-HABITAT head says in speech outlining priorities

Joan Clos, the newly elected executive director of the U.N. Human Settlements Program (UN-HABITAT), on Tuesday urged the international community to focus on improving the lives of slum dwellers worldwide and take steps to reduce the expansion of slum areas, Xinhua/People's Daily Online reports.

8 Nov 2010

FDA reviews GSK's response to Complete Response letter for Horizant

GlaxoSmithKline and XenoPort, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for review GSK's response to FDA's Complete Response letter for Horizant (gabapentin enacarbil) Extended-Release Tablets. Horizant is under review for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).

8 Nov 2010

Leaders discuss best practices, challenges for detecting counterfeit medications

During the opening of the 10th annual meeting of the International Society of Pharmacovigilance (ISoP) in Accra, Ghana, the country's "Vice President John Dramani Mahama on Wednesday called on member countries of the society to institute effective measures that would help detect fake and counterfeit drugs," Ghana News Agency reports.

8 Nov 2010

AHRQ grants $34 million to prevent healthcare-associated infections

HHS' Agency for Healthcare Research and Quality today announced the award of $34 million for projects focused on preventing one of the top 10 leading causes of death in the United States - healthcare-associated infections (HAIs). This new funding will help improve the quality of care delivered to patients and expand the fight against HAIs in hospitals, ambulatory care settings, end-stage renal disease facilities and long-term care facilities.

8 Nov 2010

How much did health care votes cause democratic defeats?

In the end, it may have mattered less whether vulnerable Democratic incumbents voted for or against the health care law than that they simply had a D by their names, The New York Times reports.

8 Nov 2010

Agios receives two grants under QTDP program to develop novel cancer metabolism therapies

Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in the rapidly emerging field of cancer metabolism, today announced it has received two grants totaling more than $488,000 from the Qualifying Therapeutic Discovery Project (QTDP) Program.

8 Nov 2010

Report: FDA conflict-of-interest rules too restrictive

The conflict-of-interest policies in the medical profession are coming under fire as too stringent and as impeding medical progress, a claim the Food and Drug Administration dismisses as a misunderstanding of its rules.

8 Nov 2010

Researchers take first step towards understanding of rare skin cancer

Leeds-based scientists, funded by Yorkshire Cancer Research headquartered in Harrogate, North Yorkshire, plan to introduce the genetic material of a virus into normal human skin cells to produce skin cells that have features of Merkel Cell Carcinoma cancers.

8 Nov 2010

Eleven Biotherapeutics receives QTDP grants for lead protein-based discovery programs

Eleven Biotherapeutics, a biopharmaceutical company focused on translating breakthrough discoveries from science and medicine to engineer and develop innovative protein-based therapeutics, today announced the receipt of three grants totaling more than $733,000 from the Qualifying Therapeutic Discovery Project (QTDP) Program.

8 Nov 2010

Sanofi Pasteur's dengue vaccine enters phase III trial in Australia

Sanofi Pasteur, the vaccines division of the pharmaceutical group Sanofi-Aventis, on Thursday announced the company had begun testing its dengue fever vaccine in a Phase III clinical trial in Australia, Dow Jones/Wall Street Journal reports.

8 Nov 2010

Genentech announces Phase II RG7204 clinical study results for metastatic melanoma tumors

Genentech, Inc., a member of the Roche Group today announced results from a Phase II clinical study of RG7204 (PLX4032), an investigational first-in-class molecule designed to selectively inhibit a cancer-causing, mutated form of the BRAF protein found in approximately half of metastatic melanoma tumors.

8 Nov 2010

Telegraph examines upcoming African mobile health summit

The Telegraph looks at the upcoming Mobile Health Africa Summit, the first event of its kind where stakeholders across Africa and the world will come together to debate the implementation of m-health across the continent.

8 Nov 2010

Deletion of 17q12 chromosomal region increases risk factor for ASD, schizophrenia

Researchers have identified the deletion of a genomic region on chromosome 17 as a significant risk factor for autism spectrum disorders (ASD) and schizophrenia. A mutation of one of the genes in the deleted interval already is a known cause of renal cysts and diabetes syndrome (RCAD).

8 Nov 2010

What's next for health law? Repeal efforts, 'compromise,' congressional conflict

Health on the Hill features Mary Agnes Carey and Marilyn Werber Serafini talking about the GOP gains, what they mean for state implementation to health reform and what possibilities there are for major changes being made to the health law.

8 Nov 2010

Research News and Research

Prolonged separation from mother increases risk of breast cancer in young mice

Health care industries have mixed reaction to health reform

Clinical Data receives $500,000 grants under QTDP program

FDA approves Cymbalta for treatment of chronic musculoskeletal pain

Alder to present data of ALD518 two clinical studies for rheumatoid arthritis at American College Meeting

Gout and hyperuricemia continue to rise in the U.S.

'New framework' needed to reduce slum expansion, new UN-HABITAT head says in speech outlining priorities

FDA reviews GSK's response to Complete Response letter for Horizant

Leaders discuss best practices, challenges for detecting counterfeit medications

AHRQ grants $34 million to prevent healthcare-associated infections

How much did health care votes cause democratic defeats?

Agios receives two grants under QTDP program to develop novel cancer metabolism therapies

Report: FDA conflict-of-interest rules too restrictive

Researchers take first step towards understanding of rare skin cancer

Eleven Biotherapeutics receives QTDP grants for lead protein-based discovery programs

Sanofi Pasteur's dengue vaccine enters phase III trial in Australia

Genentech announces Phase II RG7204 clinical study results for metastatic melanoma tumors

Telegraph examines upcoming African mobile health summit

Deletion of 17q12 chromosomal region increases risk factor for ASD, schizophrenia

What's next for health law? Repeal efforts, 'compromise,' congressional conflict

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest Life Science News